Drugs | Case | Ratio (%) | Clinical manifestations (Case) |
---|---|---|---|
Olanzapine | 54 | 39.42 | Constipation (18) / Excessive sedation (6) / Extrapyramidal reactions (4) / Lower extremity edema (4) / Abnormal liver function (3) / Decreased blood pressure (3) / Dyslipidemia (2) / Sinus bradycardia (2) / Seizures (1) / Blurred vision (1) / Dry eyes (1) / Restlessness (1) / Prolonged QT interval (1) / Dry mouth (1) / Salivation (1) / Menstruation occurs two years after menopause (1) / Albumin reduction (1) / Hyperglycemia (1) / Allergic dermatitis (1) / Skin rash (1) |
Clozapine | 38 | 27.73 | Constipation (17) / Salivation (6) / Sinus tachycardia (3) / Abnormal liver function (2) / Palpitation (1) / Epileptic seizures (1) / Akathisia (1) / Lethargy (1) / Incomplete intestinal obstruction (1) / decreased thyroid function (1) / Leukopenia (1) / Thrombocytopenia (1) / Increased blood concentration (1) / Frequent urination (1) |
Risperidone | 23 | 16.79 | Extrapyramidal reactions (4) / Hyperprolactinemia (3) / Dizziness (2) / Leukopenia (2) / Akathisia (1) / Blurred vision (1) / drowsiness (1) / Excessive sedation (1) / Sinus bradycardia (1) / Sinus tachycardia (1) / Constipation (1) / Abnormal liver function (1) / Salivation (1) / Thrombocytopenia (1) / Urination difficulty (1) / Malignant syndrome (1) |
Quetiapine | 22 | 16.06 | Constipation (4) / Leukopenia (3) / Abnormal liver function (3) / Excessive sedation (3) / Drowsiness (2) / Dizziness (1) / Dysphagia (1) / Dry mouth (1) / Hyperprolactinemia (1) / Lactation (1) / Asthenia (1) / Lower limb edema (1) |
Total | 137 | 100 |